UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - live+attenuated+vaccine
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Copyright: A Comprehensive Platform to Shorten the Period Required for Vaccine Clinical Trial (Case No. 2024-148)
Summary: UCLA researchers have developed a software to accelerate vaccine clinical trial processes by modeling disease behavior and targeting future trial participants. Background: Vaccine clinical trials are time-intensive processes; ones that may be necessary during active pandemics in which time is of short supply. One of the primary factors contributing...
Published: 11/15/2024
|
Inventor(s):
Akihiro Nishi
Keywords(s):
Bioinformatics
,
Clinical Trial
,
Live attenuated vaccine
,
Public Health
,
Simulation & Modeling
,
Software & Algorithms
,
Therapeutics & Vaccines
,
Vaccines
Category(s):
Software & Algorithms > Statistical Models
,
Software & Algorithms > Bioinformatics
Novel Safe Potent Single Vector Platform Vaccines Against Melioidosis (UCLA Case No. 2023-119)
UCLA researchers in the School of Medicine have developed a novel single-vector platform vaccine for preventing melioidosis, an infection caused by Burkholderia pseudomallei. BACKGROUND: Melioidosis, also known as Whitmore’s disease, is an infectious disease that can infect both humans and animals. The bacterium Burkholderia pseudomallei (Bp)...
Published: 2/21/2024
|
Inventor(s):
Marcus Horwitz
Keywords(s):
Burkholderia pseudomallei
,
Intracellular Pathogens
,
Live attenuated vaccine
,
Melioidosis
,
Pathogen
,
Select Agents
,
Tier 1 Diseases
,
Vaccines
Category(s):
Therapeutics > Infectious Diseases